GCAC Announces wellness Canada health Cannabis product sales permit

Vancouver, British Columbia, Canada – TheNewswire – February 4, 2021 – Global Cannabis Applications Corp. (” GCAC” or the ” business” ) (CNSX:APP.CN) (FSE:2FA) (OTC:FUAPF), a number one medical cannabis chain-of-custody conformity and information platform, today announced this has commenced the certification procedure to be a wellness Canada health product sales License owner beneath the Cannabis Act. GCAC will run as a non-possession cannabis store that connects purchasers to cultivators via wellness Canada professionals utilizing a dropship that is retail.

GCAC developed a cannabis-Consultation that is new for Efixii, where clients request an in-app assessment for medical cannabis with a registered wellness Canada practitioner. Then, according to the Cannabis Act, the practitioner makes the patient’s official Medical Document and delivers towards the GCAC store where in fact the client sales Efixii-certified medical cannabis.

GCAC’s current capital of $1 million bucks are going to be utilized to obtain a Medical Sales License and establish a dropship web shop that is retail. GCAC’s agreement that is prior Purity-IQ ensures that the Efixii store dropships trustworthy, certified medical cannabis, thus ensuring better client outcomes.

Canada may be the world’s biggest federally regulated marketplace for medical cannabis, with $600 million in medical cannabis product sales each year [1]. But, just 37% of Canadians utilizing cannabis for medical purposes have actually a ongoing health Canada Medical Document from a health-care practitioner [2]. Efixii changes that by making Medical Documents easier to acquire, from the comfort of your own home, and by also offering the quality that is highest, Efixii-certified medical cannabis direct to patients.

Brad Moore, CEO of GCAC stated, “We understand that Efixii guarantees transparency from seed to sale but we’re acutely conscious of both the possible lack of difficulty and trust in acquiring consistent medical cannabis. That’s why we developed our proprietary health-care concept that is in-app. It combines Efixii-certified cultivators running on Purity-IQ’s Cannabis Authenticity & Purity Standard (CAPS), that also calls for brands to conduct batch-to-batch systematic and fingerprint that is proprietary, to deliver the best, safest and consistent medical cannabis experience for all Canadians.”

“Our retail dropship platform delivers a new revenue that is GCAC, once we will mark-up our wholesale cannabis prices. While The Efixii health-care practitioner function shall serve to drive cultivators to adopt, and SaaS license, the Efixii-certified transparency standard.” continued Brad.

GCAC’s cannabis data is the property that is intellectual“IP”) of GCAC. The internet protocol address produces an difficulty that is inherent replicating, or directly competing with GCAC’s medical cannabis datasets. GCAC defined their protocols in a patent that is provisional, ‘System of Process and monitoring Cannabis Products and Associated Method utilizing Blockchain’ as filed with all the U.S. Patent and Trademark Office on December 17, 2020.

[1] Https* that is://mjbizdaily.com/medical-cannabis-registrations-surge-in-canada-amid-pandemic/( https://mjbizdaily.com/access-barriers-stall-canadian-medical-

-market/

About Global Cannabis Applications Corp.cannabisGlobal Cannabis Applications Corp. is a leader that is global creating, developing, SaaS certification and acquiring revolutionary information technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world’s first that is end-to-end patient to regulator – medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and* that is( industry professionals, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring quality cannabis datasets that improve patient results and also to end up being the world’s biggest

effectiveness information provider.

For more business information, please visit http://www.cannappscorp.com , or review its pages on http://www.sedar.com as well as on the Canadian Securities Exchange‘s http://www.thecse.com that is website .

Press Contact

Phone: +1 (800) 409-5679

Email: [email protected]

Forward-Looking Information

This news release may include information that is forward-looking this is of Canadian securities legislation, regarding the company of GCAC. Forward-looking information is dependant on specific expectations that are key assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such information that is forward-looking based are reasonable, undue reliance really should not be put on the forward-looking information because GCAC will give no assurance that they’ll show to be proper. Forward-looking statements included in this news launch are produced at the time of the date with this news launch. GCAC disclaims any intent or responsibility to upgrade publicly any information that is forward-looking whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this given information.

Share this:

Get Real-Time Updates from MJobserver.com(*)

Latest posts